At the time of writing, Repligen Corp [RGEN] stock is trading at $154.86, up 0.10%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The RGEN shares have gain 8.26% over the last week, with a monthly amount glided 0.09%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Repligen Corp [NASDAQ: RGEN] stock has seen the most recent analyst activity on December 17, 2024, when Canaccord Genuity initiated its Hold rating and assigned the stock a price target of $165. On August 28, 2024, Wells Fargo initiated with a Overweight rating and assigned a price target of $180 on the stock. Deutsche Bank upgraded its rating to a Buy and decreased its price target to $155 on June 26, 2024. Guggenheim initiated its recommendation with a Neutral. The Benchmark Company downgraded its rating to Hold for this stock on December 04, 2023. In a note dated July 20, 2023, Wells Fargo initiated an Overweight rating and provided a target price of $185 on this stock.
For the past year, the stock price of Repligen Corp fluctuated between $113.50 and $211.13. Currently, Wall Street analysts expect the stock to reach $201.67 within the next 12 months. Repligen Corp [NASDAQ: RGEN] shares were valued at $154.86 at the most recent close of the market. An investor can expect a potential return of 30.23% based on the average RGEN price forecast.
Analyzing the RGEN fundamentals
According to Repligen Corp [NASDAQ:RGEN], the company’s sales were 633.51M for trailing twelve months, which represents an 9.69% jump. Gross Profit Margin for this corporation currently stands at 0.47% with Operating Profit Margin at -0.01%, Pretax Profit Margin comes in at -0.0%, and Net Profit Margin reading is -0.03%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.01 and Total Capital is -0.0. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.26.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 151.80 points at the first support level, and at 148.74 for the second support level. However, for the 1st resistance point, the stock is sitting at 156.62, and for the 2nd resistance point, it is at 158.38.
Ratios To Look Out For
It is important to note that Repligen Corp [NASDAQ:RGEN] has a current ratio of 10.44. As well, the Quick Ratio is 8.76, while the Cash Ratio is 7.23. Considering the valuation of this stock, the price to sales ratio is 13.70, the price to book ratio is 4.30.
Transactions by insiders
Recent insider trading involved Hunt Anthony, Director, that happened on Nov 21 ’24 when 24246.0 shares were sold. Executive Chairman, Anthony Hunt completed a deal on Nov 21 ’24 to buy 24246.0 shares. Meanwhile, Director Hunt Anthony sold 22191.0 shares on Sep 10 ’24.
